Abstract

Mental and behavioural disorders are prevalent worldwide. These conditions account for 12% of the global burden of disease 4. It is estimated that, they will account for the loss of 15% of the disability-adjusted life-years (DALYs). Globally, these illnesses have a point prevalence of about 10% for adults. After obtaining approval and clearance from the Institutional Ethical Committee, 320 cases were included for the present study. After obtaining the informed Consent from the patients/guardians, relevant data was recorded from patient’s medical records and prescription orders. Among all the psychotropic drugs used, Risperidone had shown good improvement (n=88, 49.7%), Satisfactory improvement (n=39, 36.8%). Escitalopram showed good, satisfactory and best improvement in (25.4%), (41.5%) and (54.5%) of the population who were given the drug. Aminitriptyline and anticholinergic drug Trihexphenidyl also showed satisfactory results in terms of efficacy.

Description